- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 123,724,358
- Total 13F shares
- 137,672,960
- Share change
- +2,706,529
- Total reported value
- $4,548,776,123
- Put/Call ratio
- 31%
- Price per share
- $33.04
- Number of holders
- 308
- Value change
- +$22,757,186
- Number of buys
- 167
- Number of sells
- 175
Quarterly Holders Quick Answers
What is CUSIP 23282W605?
CUSIP 23282W605 identifies CYTK - CYTOKINETICS INC - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 23282W605:
Top shareholders of CYTK - CYTOKINETICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
13%
|
15,563,778
|
$625,508,239 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.6%
|
11,849,547
|
$476,233,294 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
8.3%
|
10,316,131
|
$414,605,291 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
8%
|
9,955,251
|
$400,102,000 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.5%
|
7,988,740
|
$321,067,461 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
6,085,001
|
$244,556,190 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
2.5%
|
3,073,853
|
$123,538,152 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,937,484
|
$118,084,206 | — | 31 Mar 2025 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
2.2%
|
2,721,158
|
$109,363,340 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.2%
|
2,702,874
|
$108,628,506 | — | 31 Mar 2025 | |
| THORNBURG INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.21%
|
260,893
|
$104,852,897 | — | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
2.1%
|
2,590,531
|
$104,113,441 | — | 31 Mar 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2%
|
2,455,737
|
$98,696,070 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
1.7%
|
2,134,219
|
$85,774,263 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.6%
|
2,028,792
|
$81,537,153 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.6%
|
1,993,896
|
$80,136,000 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.6%
|
1,956,327
|
$78,912,185 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
1,722,984
|
$69,246,712 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.2%
|
1,523,440
|
$61,227,054 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.2%
|
1,509,205
|
$60,654,949 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
1,447,316
|
$58,167,631 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
1,362,958
|
$54,777,281 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
1,325,408
|
$53,268,147 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,312,857
|
$52,763,723 | — | 31 Mar 2025 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
1.1%
|
1,310,336
|
$52,662,404 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
1%
|
1,256,580
|
$50,501,950 | — | 31 Mar 2025 | |
| Capital International Investors |
13F
|
Company |
0.94%
|
1,168,110
|
$46,946,341 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.93%
|
1,150,514
|
$46,239,157 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.85%
|
1,057,146
|
$45,665,519 | — | 31 Mar 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.89%
|
1,100,000
|
$44,209,000 | — | 31 Mar 2025 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.88%
|
1,086,300
|
$43,658,407 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.83%
|
1,023,390
|
$41,130,044 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.82%
|
1,011,745
|
$40,662,105 | — | 31 Mar 2025 | |
| Melqart Asset Management (UK) Ltd |
13F
|
Company |
0.81%
|
999,447
|
$40,167,775 | — | 31 Mar 2025 | |
| RP Management, LLC |
13F
|
Company |
0.79%
|
980,392
|
$39,401,954 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.7%
|
870,968
|
$35,004,200 | — | 31 Mar 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.69%
|
858,664
|
$34,509,706 | — | 31 Mar 2025 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.64%
|
793,458
|
$31,889,075 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.64%
|
786,583
|
$31,611,686 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.61%
|
755,706
|
$30,371,825 | — | 31 Mar 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.54%
|
673,932
|
$27,085,328 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.51%
|
629,911
|
$25,316,123 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.49%
|
602,421
|
$24,211,300 | — | 31 Mar 2025 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.48%
|
600,000
|
$24,114,000 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.47%
|
585,812
|
$23,543,784 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.44%
|
539,110
|
$21,666,831 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.43%
|
537,624
|
$21,607,093 | — | 31 Mar 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.42%
|
522,468
|
$20,997,000 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
501,882
|
$20,170,637 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.36%
|
446,828
|
$17,958,017 | — | 31 Mar 2025 |
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2025
As of 30 Jun 2025,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
137,672,960 shares.
The largest 10 holders included
T. Rowe Price Investment Management, Inc., BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Deep Track Capital, LP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, and Vestal Point Capital, LP.
This page lists
308
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
352
Q2 2025 holders
308
Holder diff
-44
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.